NPPA and cardiac hypertrophy: It leads to eccentric cardiac hypertrophy accompanied by addition of new sarcomeres in series with existing sarcomeres, as demonstrated by increased IVSd and LVIDd, decreased EF% (Fig 1B–1D), and up-regulated ANP (Fig 1E and 1F) 8 weeks after TAC.